Half year Dec 2015

The December 2013 half year saw revenue of about $8.2 million with EBITDA of just $420 k.

Since that time we have seen a full year of income from LR instruments , and the acquisition of Scanmedics in the latter half of this half year.

In attempting to get a feel of the expectation of the market at the current 36.5 cent share price I suspect the expectation is for about $13 million revenue in the December 2014 half year .

In 2103/14 we saw revenue jump from $8.2 million in the December half to to over $10 million in the Jan to June 30 2014 half year , up about 20% .

In this years I am hoping we see a larger jump than 20% on the 2nd half revenue because of Scanmedics

The $13 million target I think we will see in the first half 2014/15 would actually be 60% higher than the corresponding period in 2013.

If we see a 60% jump in the corresponding period June to December that would be a revenue target of $8.2 million /1.6 = $13 million.

If we expect to have $30 million revenue as the full year number, the 2nd half revenue will need to be $17 million or 30% higher in the 2nd half if my $13 million number is accurate .

That makes sense as Scanmedics will be 6 months instead of 2 months income in the 2nd half and from my understanding the 2nd half is the best half for PGC as the hospitals and aged care centres spend in the 2nd half to clear for new budget allocations .

I suspect that sort of a result is the expectation.

A 30m revenue up 50% year on year and achieving a growing $4 million ebit to me suggests a market of $ 30 million as cheap to me

At 36.5 cents share price the market cap is even less than that , so does that mean the expectations are less , or is PGC still unknown to most of the market ?

Been thinking of buying some more over the Christmas break but I cant understand why the price is stalled at 36.7-37 cents when the chart looked like the back of the sellers had been broken a few weeks ago and some of the people who bought in to medibank at a PE of 20 looked at the sector for other opportunities at lower price multiples .

What do others think we need to see for a full year in revenue and ebit to move to a 50 cents - $1.00 share price